| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 23978-09-8 | 4,7,13,16,21,24-六氧-1,10-二氮雙環(huán)[8.8.8]二十六烷 | Kryptofix 222; 4,7,13,16,21,24-Hexaoxa-1,10-diazabicyclo[8.8.8]-hexacosane |  | C18H36N2O6 | 詳情 | 供應(yīng)商 |
| 23978-55-4 | 1,4,10,13-四氧雜-7,16-二氮雜環(huán)十八烷; 1,10-二氮雜-18-冠醚-6 | 1,4,10,13-Tetraoxa-7,16-diazacyclooctadecane; 1,10-Diaza-18-crownether; 1,10-Diaza-18-crown-6; 1,10-Diaza-4,7,13,16-tetraoxa-18-crown-6; 1,10-Diaza-4,7,13,16-tetraoxacyclooctadecane; 1,7,10,16-Tetraoxa-4,13-diazacyclooctadecane; 2,2'-Kryptofix; 4,13-Diaza-18-crown-6; 4,7,13,16-Tetraoxa-1,10-diazacyclooctadecane; 7,16-Diaza-1,4,10,13-tetraoxacyclooctadecane; 7,16-Diaza-18-crown-6; Cryptand22; Cryptand(2.2); Crytand[2,2]; Diaza crown ether 22; Diaza-18-crown-6; Kryptand[2.2]; Kryptofix 22; Kryptofix[2.2]; NSC 339325 |  | C12H26N2O4 | 詳情 | 供應(yīng)商 |
| 23978-10-1 | 1,4,7,13,16-Pentaoxa-10,19-diazacycloheneicosane; 1,13-Diaza-21-crown-7; Kryptofix 23; Kryptofix 3.2 |  | C14H30N2O5 | 詳情 | 供應(yīng)商 | |
| 239783-48-3 | 2(1H)-Naphthalenone,3,4-dihydro-6-iodo-; 6-Iodo-2-tetralone |  | C10H9IO | 詳情 | 供應(yīng)商 | |
| 23978-85-0 | II-NOR-9-TETRAHYDROCANNABINOL-9-CARBOXYL IC ACID (THC-COOH) (5; II-NOR-9-TETRAHYDROCANNABINOL-9-CARBOXYL IC ACID (THC-COOH) (5; delta(9)-tetrahydrocannabinolic acid; 6H-Dibenzo(B,D)pyran-2-carboxylic acid, 6A,7,8,10A-tetrahydro-1-hydroxy-6,6,9-trimethyl-3-pentyl-, (6ar,10ar)-; 6H-Dibenzo(B,D)pyran-2-carboxylic acid, 6abeta,7,8,10A-tetrahydro-1-hydroxy-6,6,9-trimethyl-3-pentyl-, (6ar-trans)-; 9-Carboxy-delta(9)-thc; 9-Carboxy-thc; Dea no. 7370; Tetrahydrocannabinols |  | C22H30O4 | 詳情 | 供應(yīng)商 |